Navigation Links
Cedars-Sinai awarded $2.5 million to study potential new drug treatments for Alzheimer's disease
Date:2/21/2012

LOS ANGELES (Feb. 20, 2012) A Cedars-Sinai research scientist has been awarded two national grants totaling more than $2.5 million, including a prestigious Research Project Grant from the National Institutes of Health to study potential treatments for Alzheimer's disease.

Terrence Town, PhD, is studying drugs that potentially could disrupt the formation and accumulation of sticky amyloid plaques that build up in the brain and are widely considered a root cause of Alzheimer's disease, a chronic and fatal condition that impairs memory and cognition. In the disease's final stages, patients require round-the-clock care.

Amyloid is an abnormal protein usually produced in the bone marrow that can be deposited in any tissue or organ. An unhealthy buildup of the protein is believed to lead to diseases such as Alzheimer's.

"Alzheimer's has the potential to bankrupt this country,'' said Town, PhD, the studies' principal investigator and research scientist in the Cedars-Sinai Regenerative Medicine Institute and the Departments of Biomedical Sciences and Neurosurgery. "It is the public health crisis of our time and the big question is: what are we going to do about it? Our approach is to target the body's immune system to clean up amyloid plaques and thereby allow brain regeneration."

The NIH grant totals more than $2 million over five years and is earmarked for the study of macrophages, common cells that circulate in the blood and are capable of clearing damaging substances, such as plaques.

"Our goal is to identify drugs that give the signal to macrophages to enter the brain and eat away at the amyloid plaque buildup," said Town, the Ben Winters Chair in Regenerative Medicine. "These macrophages have a central mission in life: to eat noxious substances. But because the brain is somewhat shielded from the immune system, peripheral macrophages are given the message not to go into the brain and eat the amyloid plaques. So, if we could identify what's blocking this beneficial response in these cells, the hope is that a drug would enable the macrophages to leave the blood, go into the brain and remove the plaques."

The second grant, for $550,000, was awarded by the American Federation of Aging Research and will enable Town and his team of researchers to study new ways to reduce brain inflammation.

"Understanding this important area of neuroimmunology will likely lead to new therapeutic targets for Alzheimer's,'' Town said.

The author of more than 90 scientific publications, Town is a well-known neuroimmunologist whose research focuses on understanding and treating neurologic disorders including Alzheimer's, viral encephalitis and stroke.

According to the Alzheimer's Association, more than 5.4 million Americans have the disease, and its incidence is on the rise. Alzheimer's destroys brain cells, causing memory, thinking and behavioral problems severe enough to affect work, family and social relationships. It eventually affects the basics of daily living, is incurable and, ultimately, is fatal. Alzheimer's is the sixth-leading cause of death in the United States and the fifth-leading cause for people 65 and older, association statistics show.


'/>"/>

Contact: Sally Stewart
Sally.stewart@cshs.org
310-248-6566
Cedars-Sinai Medical Center
Source:Eurekalert

Related medicine news :

1. Moderate red wine drinking may help cut womens breast cancer risk, Cedars-Sinai study shows
2. Cedars-Sinai study: How does a good protein hurt brain cells after clot-induced stroke?
3. TGen and Virginia G. Piper Cancer Center form drug development collaboration with Cedars-Sinai
4. Cedars-Sinai scientists, physicians to be key presenters at World Stem Cell Summit
5. Cedars-Sinai movement disorders expert on international task force for dystonia treatment
6. Latest data from Cedars-Sinai vaccine study supports immune targeting of brain tumors
7. Cedars-Sinais mobile medical clinics receive $500,000 grant from California Community Foundation
8. Cedars-Sinai to hold first annual conference on stem cell therapies for neurological disorders
9. Cedars-Sinais mobile medical clinics receive grant from George Hoag Family Foundation
10. Cedars-Sinai research team awarded $1.9 million from CIRM to develop new tools and technologies
11. Cedars-Sinai Medical Genetics Institute director honored with lifetime achievement award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Living, is proud to recognize Dr. Barry M. Weintraub as a prominent plastic ... most beautiful women in the world, and the most handsome men, look naturally ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: